Task: Answer the multiple-choice question.
Question: Which drug exhibits a -45.284\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) COC(=O)[C@H](CCSC)NC(=O)Nc1ccc(C)c(C)c1
b.) O=C(Nc1ccncc1)Nc1cccc(Cl)c1
Answer: a. COC(=O)[C@H](CCSC)NC(=O)Nc1ccc(C)c(C)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)[C@H](CCSC)NC(=O)Nc1ccc(C)c(C)c1
COC(=O)[C@H](CCSC)NC(=O)Nc1ccc(C)c(C)c1
methyl (2S)-2-[(3,4-dimethylphenyl)carbamoylamino]-4-methylsulfanylbutanoate